(FY)Dec 30, 2023 | (FY)Dec 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 0.52%-9.69M | -9.74M |
Other cash income from operating activities | 0.52%-9.69M | ---9.74M |
Cash paid | ||
Direct interest received | 317.17%179.54K | --43.04K |
Operating cash flow | 1.93%-9.51M | ---9.7M |
Investing cash flow | ||
Cash flow from continuing investing activities | -1,008.34%-4.71M | -425.26K |
Capital expenditure reported | -1,206.35%-4.71M | ---360.48K |
Net PPE purchase and sale | 93.62%-4.13K | ---64.78K |
Cash from discontinued investing activities | ||
Investing cash flow | -1,008.34%-4.71M | ---425.26K |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.78%-214.63K | 27.63M |
Net issuance payments of debt | ---- | --5M |
Net common stock issuance | ---- | --28.66M |
Interest paid (cash flow from financing activities) | 7.12%-30.97K | ---33.34K |
Net other financing activities | 96.94%-183.66K | ---6M |
Cash from discontinued financing activities | ||
Financing cash flow | -100.78%-214.63K | --27.63M |
Net cash flow | ||
Beginning cash position | 1,214.62%18.96M | --1.44M |
Current changes in cash | -182.46%-14.44M | --17.51M |
Effect of exchange rate changes | -232.24%-11.5K | --8.7K |
End cash Position | -76.21%4.51M | --18.96M |
Free cash from | -40.52%-14.22M | ---10.12M |
Accounting Standards | US-GAAP | US-GAAP |
No Data